This section gives examples of the potential start sites of miranda-predicted MREs within Influenza A viruses, dengue types 1-4, and rabies according to their conserved start binding positions of specific miRNAs within or across gene sets.
We speculate that, for certain genes, some of their transcription forms lost the miRNA binding sites during evolution, thus partially eliminating the regulatory effects of specific miRNAs.
The database dPORE-miRNA, as presented here, complements existing repositories and represents an easy means to investigate the regulatory regions of specific miRNAs of interest for SNPs that potentially affect miRNA regulation and shows the specific effects on binding sites.
The study revealed a number of specific miRNAs for this condition: miRNA-15b, miRNA-16, miRNA-20b, miRNA-25, miRNA-26b, miRNA-27b, miRNA-28-5p, miRNA-126, miRNA-195, miRNA-335, and miRNA-363 [ 35].
A recent approach to test the binding of proteins to miRNA in cellular extract and in the cell [ 45] could be a predictor for potential effects on the biogenesis of specific miRNAs in vivo.
MicroRNAs (miRNAs) are ∼21 24 nucleotide RNAs that mediate repression of messenger RNA (mRNA) translation through recognition of specific miRNA binding sites usually located in the 3′ non-translated region.
They designed and engineered tandem repeats of specific miRNA binding sites into the 3′-UTR of green fluorescent protein reporter genes and demonstrated more effective inhibition of miRNA function compared to other methods such as antagomirs.
Inactivation of specific miRNA by virus-encoded target RNAs or virus-encoded miRNA binding proteins in virus infected cells has been reported previously (Belair et al., 2011; Cazalla et al., 2010; Libri et al., 2012).
By doing so, they act as a binding site for specific miRNAs and functionally inhibit miRNA binding to native targets [101].
In general, the binding of miRNAs to specific target genes (mainly the TAS family genes) leads to the cleavage of target genes at the middle of miRNA binding sites [22].
